Final overall survival in the phase 3 NETTER-1 study of lutetium-177-DOTATATE in patients with midgut neuroendocrine tumors.
Jonathan R. Strosberg,Martyn E. Caplin,Pamela L. Kunz,Philippe B. Ruszniewski,Lisa Bodei,Andrew Eugene Hendifar,Erik Mittra,Edward M. Wolin,James C. Yao,Marianne E. Pavel,Enrique Grande,Eric Van Cutsem,Ettore Seregni,Hugo Duarte, Germo Gericke, Amy Bartalotta, Arnaud Demange, Sakir Mutevelic,Eric Krenning JOURNAL OF CLINICAL ONCOLOGY（2021）
AI 理解论文
溯源树
样例
